Cargando…

Do all patients with breast cancer benefit from neoadjuvant chemotherapy?

Detalles Bibliográficos
Autor principal:	Lee, Kyoung Eun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652643/ https://www.ncbi.nlm.nih.gov/pubmed/33147906 http://dx.doi.org/10.3904/kjim.2020.535

Ejemplares similares

Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?
por: Yao, Liqin, et al.
Publicado: (2022)

Radiological assessment of neoadjuvant chemotherapy in breast cancer
por: Ollivier, Liliane
Publicado: (2015)

Do patients with advanced breast cancer benefit from chemotherapy?
por: Ramirez, A. J., et al.
Publicado: (1998)

Breast Cancer Subtype Specific Classifiers of Response to Neoadjuvant Chemotherapy Do Not Outperform Classifiers Trained on All Subtypes
por: de Ronde, Jorma J., et al.
Publicado: (2014)

Rectal cancer patients with downstaging after neoadjuvant chemoradiotherapy and radical resection do not benefit from adjuvant chemotherapy
por: Zhang, Hang, et al.
Publicado: (2020)

Response to neoadjuvant chemotherapy in breast cancer: do microRNAs matter?
por: Ryspayeva, Dinara, et al.
Publicado: (2022)

Survival benefit of neoadjuvant chemotherapy for resectable breast cancer: A meta-analysis
por: Chen, Yan, et al.
Publicado: (2018)

Relative Survival Benefit by Hormonal Receptor Status of Adding Trastuzumab to Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Schneider, Jean, et al.
Publicado: (2020)

Predicting neoadjuvant chemotherapy benefit using deep learning from stromal histology in breast cancer
por: Li, Fengling, et al.
Publicado: (2022)

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
por: Melchior, Nicole M., et al.
Publicado: (2020)

Potential Benefits of Neoadjuvant Chemotherapy in Clinically Node-Positive Luminal Subtype(−) Breast Cancer
por: Kim, Hyung Suk, et al.
Publicado: (2019)

Neoadjuvant treatment: the future of patients with breast cancer
por: Reyal, F, et al.
Publicado: (2018)

Breast Cancer–Related Lymphedema after Neoadjuvant Chemotherapy
por: Kim, Myungsoo, et al.
Publicado: (2015)

Can Gastric Cancer Patients with High Mandard Score Benefit from Neoadjuvant Chemotherapy?
por: Kang, Wen-Zhe, et al.
Publicado: (2022)

Increased Malignant Microcalcifications after Neoadjuvant Chemotherapy in Advanced Breast Cancer
por: Shin, Gi Won, et al.
Publicado: (2016)

Neoadjuvant therapy in localized non-small cell lung cancer: can we do better than chemotherapy?
por: Chau, Brittney, et al.
Publicado: (2019)

Neoadjuvant treatment for male breast cancer
por: Fentiman, Ian Stuart
Publicado: (2023)

Do patients benefit from platelet-rich plasma?
por: Atik, O. Şahap
Publicado: (2020)

Do all daily metabolic equivalent task units (METs) bring the same health benefits?
por: Holtermann, Andreas, et al.
Publicado: (2019)

Refining the use of neoadjuvant chemotherapy in locally advanced bladder cancer: from conviction to optimization
por: Culine, Stéphane, et al.
Publicado: (2018)

The survival benefit of neoadjuvant chemotherapy and pCR among patients with advanced stage triple negative breast cancer
por: Biswas, Tithi, et al.
Publicado: (2017)

Evaluating the role of neoadjuvant chemotherapy in bladder cancer patients with occult lymph node metastases
por: Moschini, Marco, et al.
Publicado: (2018)

The timing of radical cystectomy following neoadjuvant chemotherapy
por: Ramakrishnan, Venkat M., et al.
Publicado: (2018)

Outcome after neoadjuvant chemotherapy in Asian breast cancer patients
por: Lim, Li Yan, et al.
Publicado: (2016)

Do we need biomarkers to predict the benefit of adding adjuvant taxanes for treatment of breast cancer?
por: Pérez-García, José, et al.
Publicado: (2012)

Is adjuvant chemotherapy better than neoadjuvant chemotherapy for those with node positive disease?
por: Zabell, Joseph, et al.
Publicado: (2018)

Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
por: Wang, Huan, et al.
Publicado: (2020)

Prediction of neoadjuvant chemotherapy response in breast cancer
por: Myllys, Maiju
Publicado: (2021)

Do early HER2-overexpression breast cancer patients benefit from undergoing neoadjuvant trastuzumab and mastectomy? A meta-analysis
por: He, Lin, et al.
Publicado: (2019)

Comparison of breast tissue markers for tumor localization in breast cancer patients undergoing neoadjuvant chemotherapy
por: Koo, Ja Ho, et al.
Publicado: (2019)

Do older patients truly benefit from advances in myeloma care?
por: Gatt, Moshe E., et al.
Publicado: (2022)

Effects of neoadjuvant chemotherapy on respiratory function in patients with breast cancer
por: Ding, Lei, et al.
Publicado: (2020)

Neoadjuvant chemotherapy modulates exhaustion of T cells in breast cancer patients
por: Rodríguez, Ivon Johanna, et al.
Publicado: (2023)

Management of the axilla after neoadjuvant chemotherapy in breast cancer patients
por: Boland, M R, et al.
Publicado: (2021)

Do all patients with advanced N-stage nasopharyngeal carcinoma benefit from the addition of induction chemotherapy to concurrent chemoradiotherapy?
por: Yao, Ji-Jin, et al.
Publicado: (2019)

Do Nostrums Benefit Consumers?
Publicado: (1879)

Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence?
por: Turner, Nicholas C, et al.
Publicado: (2012)

Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy
por: Sánchez-Margalet, Víctor, et al.
Publicado: (2019)

Survival benefit of neoadjuvant chemotherapy in pathologic T2N0 or lower urothelial carcinoma patients: evidence to support the use of neoadjuvant chemotherapy
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Benefit of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Bidirectional Chemotherapy for Patients with Gastric Cancer with Peritoneal Carcinomatosis Considering Cytoreductive Surgery
por: Yu, Hsin-Hsien, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ibvoci6f7rbrmoqujvh7ko84tb